Use este identificador para citar ou linkar para este item: http://repo.saocamilo-sp.br:8080/jspui/handle/123456789/1988
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorCestari, Silmara da Costa Pereiraen_US
dc.contributor.authorCestari, Marcela da Costa Pereiraen_US
dc.contributor.authorMarques, Gabriela Francoen_US
dc.contributor.authorLirio, Ivanaen_US
dc.contributor.authorTovo, Reinaldoen_US
dc.contributor.authorLabriola, Ilana Cruz Silvaen_US
dc.date.accessioned2024-09-09T17:45:54Z-
dc.date.available2024-09-09T17:45:54Z-
dc.date.issued2023-
dc.identifier.citationCestari, Silmara da Costa Pereira, et al. “Cutaneous manifestations of COVID-19 patients in a Hospital in São Paulo, Brazil, and global literature review”. Anais Brasileiros de Dermatologia, vol. 98, no 4, julho de 2023, p. 466–71. DOI.org (Crossref), https://doi.org/10.1016/j.abd.2022.09.007.en_US
dc.identifier.issn0365-0596-
dc.identifier.urihttp://repo.saocamilo-sp.br:8080/jspui/handle/123456789/1988-
dc.description.abstractBackground: Since the beginning of the COVID-19 pandemic, a myriad of cutaneous manifesta tions have been described in association with this viral infection. However, in Latin America, this kind of data is still scarce. Objective: In this sense, the goal of this study was to describe the dermatological findings observed during SARS-CoV-2 infection, in a Brazilian Hospital. Methods: This is a cross-sectional, retrospective and descriptive study of 50 cases of new onset dermatologic symptoms in patients with COVID-19, treated at Hospital Sírio-Libanês, from February to June 2020. Results: The patients (n = 50) were classified into 6 groups, according to the elementary lesions and the statistical analysis was performed. The most common cutaneous lesions were maculopapular eruptions (44%), necrosis, purpura, and livedo (32%), urticarial lesions (12%), pseudochilblains (4%) and papular-vesicular eruption (4%). In 46% of the patients the cutaneous lesions occurred in association with other symptoms, such as pruritus (38%), pain and burning sensation (8%). Lower limbs were affected in 44% of the cases, followed by the trunk (38%), upper limbs (24%) and face (14%). Cutaneous lesions were mostly found after other COVID-19 systemic symptoms, with a mean period between the viral syndrome and cutaneous signs of 5 days (SD = 6.1 days). Study limitations: It is a small sample, in a single-center study, with patients exclusively from a private Hospitals. Conclusions: Patients in Brazil have the same proportion of lesions as revealed in other studies in Europa. The compiled data is essential for a better understanding of cutaneous manifestations deemed secondary to COVID.en_US
dc.publisherSociedade Brasileira de Dermatologiaen_US
dc.relation.ispartofAnais brasileiros de dermatologia, v.98, n.4, 2023, p. 466-471en_US
dc.subjectCovid -19en_US
dc.subjectManifestações cutâneasen_US
dc.subjectSARS-CoV-2en_US
dc.subjectPandemiasen_US
dc.titleCutaneous manifestations of COVID-19 patients in a Hospital in São Paulo, Brazil, and global literature reviewen_US
dc.typeArtigo de Periódicoen_US
dc.identifier.doi10.1016/j.abd.2022.09.007-
Aparece nas coleções:Artigos de Periódicos

Arquivos associados a este item:
Não existem arquivos associados a este item.


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.